Home › Compare › STXMF vs MRK

STXMF vs MRK: Dividend Comparison 2026

STXMF yields 222222.22% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STXMF wins by $1.4076447531278624e+30M in total portfolio value
10 years
STXMF
STXMF
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076447531278624e+30M
Annual income
$1,406,399,782,569,334,400,000,000,000,000,000,000.00
Full STXMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — STXMF vs MRK

📍 STXMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTXMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STXMF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
STXMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STXMF
Annual income on $10K today (after 15% tax)
$18,888,888.89/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,815,183,934,200,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, STXMF beats the other by $1,195,439,815,183,934,200,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STXMF + MRK for your $10,000?

STXMF: 50%MRK: 50%
100% MRK50/50100% STXMF
Portfolio after 10yr
$7.038223765639312e+29M
Annual income
$703,199,891,284,667,200,000,000,000,000,000,000.00/yr
Blended yield
99.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

STXMF
No analyst data
Altman Z
-2.3
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STXMF buys
0
MRK buys
0
No recent congressional trades found for STXMF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTXMFMRK
Forward yield222222.22% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$1.4076447531278624e+30M$56.8K ✓
Annual income after 10y$1,406,399,782,569,334,400,000,000,000,000,000,000.00 ✓$9,798.13
Total dividends collected$1.4075632434891558e+30M$28.9K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: STXMF vs MRK ($10,000, DRIP)

YearSTXMF PortfolioSTXMF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$22,232,922$22,222,222.22$11,206$366.19+$22.22M → STXMF
2$46,198,082,523$46,174,293,296.41$12,650$502.35+$46198.07M → STXMF
3$89,718,752,943,223$89,669,320,994,923.30$14,407$694.19+$89718752.93M → STXMF
4$162,845,393,609,755,680$162,749,394,544,106,430.00$16,585$967.82+$162845393609.74M → STXMF
5$276,249,735,879,778,500,000$276,075,491,308,616,120,000.00$19,342$1,363.89+$276249735879778.47M → STXMF
6$437,989,462,258,048,500,000,000$437,693,875,040,657,100,000,000.00$22,913$1,947.19+$437989462258048512.00M → STXMF
7$649,026,142,700,674,900,000,000,000$648,557,493,976,058,700,000,000,000.00$27,662$2,823.89+$649026142700674875392.00M → STXMF
8$898,874,153,179,794,200,000,000,000,000$898,179,695,207,104,400,000,000,000,000.00$34,159$4,173.35+$8.988741531797941e+23M → STXMF
9$1,163,523,886,474,633,300,000,000,000,000,000$1,162,562,091,130,731,000,000,000,000,000,000.00$43,337$6,308.80+$1.1635238864746333e+27M → STXMF
10$1,407,644,753,127,862,300,000,000,000,000,000,000$1,406,399,782,569,334,400,000,000,000,000,000,000.00$56,776$9,798.13+$1.4076447531278624e+30M → STXMF

STXMF vs MRK: Complete Analysis 2026

STXMF — Stock

Starrex International Ltd., together with its subsidiaries, acquires, manages, and grows companies active in mortgage, real estate, and other financial sectors in the United States. The company operates through four segments: Property Interlink, LLC; Starrex International Ltd.; MFI Credit Solutions, LLC; and Reliable Valuation Service, LLC. It manages residential appraisals, as well as maintains ordering, tracking, administrative duties, and details; and ensures the timeliness of appraisals that are handled during a real estate mortgage transaction. The company also provides consumer credit reports to the real estate industry and consumer service companies; and residential real estate evaluation services to third parties. It primarily serves mortgage banks and brokers. The company was formerly known as Starrex Mining Corporation Limited and changed its name to Starrex International Ltd. in May 2014. Starrex International Ltd. was incorporated in 1982 and is headquartered in Calgary, Canada.

Full STXMF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this STXMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STXMF vs SCHDSTXMF vs JEPISTXMF vs OSTXMF vs KOSTXMF vs MAINSTXMF vs JNJSTXMF vs ABBVSTXMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.